Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin‐3A
Abstract The MDM2‐antagonist Nutlin 3A can efficiently induce apoptosis in osteosarcoma cell lines with amplified MDM2 . However, Nutlin‐based therapy could be even more importa...